Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3603-3617

  England, Christopher G ^a   Priest, Thomas ^b   Zhang, Guandong ^b   Sun, Xinghua ^b   Patel, Dhruvinkumar N ^b   McNally, Lacey R ^a,c   van Berkel, Victor ^a,c   Gobin, André M ^b   Frieboes, Hermann B ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b University of Louisville   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cancer nanotherapy; Nanovector transport; Tumor hypoxia

Indexed keywords

GOLD NANOPARTICLE; HIGH DENSITY LIPOPROTEIN; MACROGOL; NANOSHELL; PHOSPHATIDYLCHOLINE; SILICON DIOXIDE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CANCER; LUNG CANCER; PANCREAS CANCER; PARTICLE SIZE; SILVER STAINING; TUMOR SPHEROID; ZETA POTENTIAL;

CANCER NANOTHERAPY; NANOVECTOR TRANSPORT; TUMOR HYPOXIA;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DIFFUSION; GOLD; HUMANS; METAL NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TISSUE DISTRIBUTION;

EID: 84885079567     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51668     Document Type: Article

References (61)

1. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 2000;60(16): 4440-4445.
2. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189-207.
3. Murphy CJ, Gole AM, Stone JW, etal. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res. 2008;41(12): 1721-1730.
4. Zamboni WC, Torchilin V, Patri AK, etal. Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res. 2012;18(12):3229-3241.
5. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res. 2010;12(7): 2313-2333.
6. Kennedy LC, Bickford LR, Lewinski NA, etal. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small. 2011;7(2):169-183.
7. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15(4):897-900.
8. Chabner BA. Cancer Chemotherapy and Biotherapy: Principles and Practice. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2011.
9. Vinci M, Gowan S, Boxall F, etal. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29.
10. Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2(12):1117-1133.
11. van de Ven AL, Wu M, Lowengrub J, etal. Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv. 2012;2(1):11208.
12. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631-651.
13. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47(12):3039-3051.
14. van de Ven A, Abdollahi B, Martinez C, etal. Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys. 2013;15:055004.
15. Wu M, Frieboes HB, McDougall SR, Chaplain MA, Cristini V, Lowengrub J. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol. 2013;320:131-151.
16. Michor F, Liphardt J, Ferrari M, Widom J. What does physics have to do with cancer? Nat Rev Cancer. 2011;11(9):657-670.
17. Wong C, Stylianopoulos T, Cui J, etal. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011;108(6):2426-2431.
18. Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomedicine. 2007;2(2):265-274.
19. Huang K, Ma H, Liu J, etal. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012;6(5):4483-4493.
20. Cabral H, Matsumoto Y, Mizuno K, etal. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815-823.
21. Garrett N, Whiteman M, Moger J. Imaging the uptake of gold nanoshells in live cells using plasmon resonance enhanced four wave mixing microscopy. Opt Express. 2011;19(18):17563-17574.
22. Liang Z, Liu Y, Li X, etal. Surface-modified gold nanoshells for enhanced cellular uptake. J Biomed Mater Res A. 2011;98(4):479-487.
23. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-668.
24. Frieboes HB, Edgerton ME, Fruehauf JP, etal. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res. 2009;69(10):4484-4492.
25. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett. 2011;205(2): 105-115.
26. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse Gold solutions. Nature Phys Sci. 1973;241:20-22.
27. Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci. 1968;26(1): 62-69.
28. Kalele S, Gosavi SW, Urban J, Kulkarni AK. Nanoshell particles: synthesis, properties and applications. Current Sci. 2006;91(8):1038-1052.
29. Preston TC, Signorell R. Growth and optical properties of gold nanoshells prior to the formation of a continuous metallic layer. ACS Nano. 2009;3(11):3696-3706.
30. Duff DG, Baiker A, Edwards PP. A new hydrosol of gold clusters. 1. Formation and particle size variation. Langmuir. 1993;9(9):2301-2309.
31. Guan M, Zhou Y, Zhu QL, etal. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine. 2012;8(7):1172-1181.
32. Wang J, Zhang Z, Wang X, Wu W, Jiang X. Size-and pathotropism-driven targeting and washout-resistant effects of boronic acid-rich protein nanoparticles for liver cancer regression. J Control Release. 2013;168(1):1-9.
33. Lai LF, Guo HX. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm. 2011;404(1-2):317-323.
34. Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, Plech A. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B. 2006;110(32):15700-15707.
35. Leung K. Gold-polyethylene glycol nanoshells. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda: National Center for Biotechnology Information (US); 2004-2013.
36. Tullman JA, Finney WF, Lin YJ, Bishnoi SW. Tunable assembly of peptide-coated gold nanoparticles. Plasmonics. 2007;2(3):119-127.
37. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209(2):171-176.
38. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007;7(7):1929-1934.
39. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6(4): 715-728.
40. Maldiney T, Richard C, Seguin J, Wattier N, Bessodes M, Scherman D. Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice. ACS Nano. 2011;5(2):854-862.
41. Gu X, Zhang W, Liu J, etal. Preparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cells. AAPS Pharm Sci Tech. 2011;12(4):1200-1208.
42. Wen SH, Zheng F, Shen M, Shi X. Surface modification and PEGylation of branched polyethyleneimine for improved biocompatibility. J Appl Polymer Sci. 2013;128(6):3807-3813.
43. Lewis BA, Engelman DM. Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. J Mol Biol. 1983;166(2):211-217.
44. Nagle JF, Tristram-Nagle S. Structure of lipid bilayers. Biochim Biophys Acta. 2000;1469:159-195.
45. El Harchaoui K, Arsenault BJ, Franssen R, etal. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150(2):84-93.
46. Kumar C, editor. Mixed Metal Nanomaterials. Weinheim: Wiley-VCH Verlag GmbH; 2009.
47. Rothe DR, Wood SP, Heeschen WA. Imaging of submicron particulate in an optical flow cell. Microsc Microanal. 2007;13(Suppl S02):672-673.
48. Yen JC, Chang FJ, Chang S. A new criterion for automatic multilevel thresholding. IEEE Trans Image Process. 1995;4(3):370-378.
49. Nanospectra Nanosciences, Inc [homepage on the Internet]. Available from: http://www.nanospectra.com. Accessed April 15, 2013.
50. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir. 2006;22(1):2-5.
51. Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine. 2006;1(2):149-154.
52. Kojima C, Hirano Y, Kono K. Chapter7-Preparation of complexes of liposomes with gold nanoparticles. Meth Enzymol. 2009;464: 131-145.
53. Jiang J, Nilsson-Ehle P, Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis. 2006;5:4.
54. Shahzad MM, Mangala LS, Han HD, etal. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia. 2011;13(4):309-319.
55. Ng KK, Lovell JF, Zheng G. Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res. 2011;44(10):1105-1113.
56. Blume G, Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta. 1993;1146(2):157-168.
57. Krilov D, Balarin M, Kosović M, Gamulin O, Brnjas-Kraljević J. FT-IR spectroscopy of lipoproteins-a comparative study. Spectrochim Acta A Mol Biomol Spectrosc. 2009;73(4):701-706.
58. Semalty A, Semalty M, Singh D, Rawat MSM. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem. 2010;67:253-260.
59. Wang F, Yang ZL, Zhang L, Weng SF, Wu JG. FT-IR study of the interaction between phosphatidylcholine and bovine serum albumin. Acta Physico-Chimica Sinica. 2004;20:1186-1190.
60. Gupta AK, Curtis AS. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med. 2004;15(4):493-496.
61. Frieboes HB, Wu M, Lowengrub J, Decuzzi P, Cristini V. A computational model for predicting nanoparticle accumulation in tumor vasculature. PLoS One. 2013;8(2):e56876.